CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM NEW
Total 13F shares
7,241,805
Share change
-140,630
Total reported value
$33,020,000
Price per share
$4.56
Number of holders
38
Value change
-$1,076,847
Number of buys
20
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q4 2019

As of 31 Dec 2019, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,241,805 shares. The largest 10 holders included Nantahala Capital Management, LLC, ROYCE & ASSOCIATES LP, SILVERCREST ASSET MANAGEMENT GROUP LLC, VANGUARD GROUP INC, SEGALL BRYANT & HAMILL, LLC, ARS Investment Partners, LLC, GAGNON SECURITIES LLC, INGALLS & SNYDER LLC, Gagnon Advisors, LLC, and BlackRock Inc.. This page lists 38 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.